The Role of Sphingosine-1-Phosphate Transporter Spns2 in Immune System Function

Sphingosine-1-phosphate (S1P) is lipid messenger involved in the regulation of embryonic development, immune system functions, and many other physiological processes. However, the mechanisms of S1P transport across cellular membranes remain poorly understood, with several ATP-binding cassette family members and the spinster 2 (Spns2) member of the major facilitator superfamily known to mediate S1P transport in cell culture. Spns2 was also shown to control S1P activities in zebrafish in vivo and to play a critical role in zebrafish cardiovascular development. However, the in vivo roles of Spns2 in mammals and its involvement in the different S1P-dependent physiological processes have not been investigated. In this study, we characterized Spns2-null mouse line carrying the Spns2tm1a(KOMP)Wtsi allele (Spns2tm1a). The Spns2tm1a/tm1a animals were viable, indicating a divergence in Spns2 function from its zebrafish ortholog. However, the immunological phenotype of the Spns2tm1a/tm1a mice closely mimicked the phenotypes of partial S1P deficiency and impaired S1P-dependent lymphocyte trafficking, with a depletion of lymphocytes in circulation, an increase in mature single-positive T cells in the thymus, and a selective reduction in mature B cells in the spleen and bone marrow. Spns2 activity in the nonhematopoietic cells was critical for normal lymphocyte development and localization. Overall, Spns2tm1a/tm1a resulted in impaired humoral immune responses to immunization. This study thus demonstrated a physiological role for Spns2 in mammalian immune system functions but not in cardiovascular development. Other components of the S1P signaling network are investigated as drug targets for immunosuppressive therapy, but the selective action of Spns2 may present an advantage in this regard.

[1]  D. Stainier,et al.  The Spinster Homolog, Two of Hearts, Is Required for Sphingosine 1-Phosphate Signaling in Zebrafish , 2008, Current Biology.

[2]  H. Kiyono,et al.  Sphingosine 1-phosphate dependence in the regulation of lymphocyte trafficking to the gut epithelium , 2007, The Journal of experimental medicine.

[3]  R. Wadgaonkar,et al.  Sphingosine Kinase-1 (SphK-1) Regulates Mycobacterium smegmatis Infection in Macrophages , 2010, PloS one.

[4]  I. Paulsen,et al.  Major Facilitator Superfamily , 1998, Microbiology and Molecular Biology Reviews.

[5]  R. Proia,et al.  Essential Role for Sphingosine Kinases in Neural and Vascular Development , 2005, Molecular and Cellular Biology.

[6]  S. Payne,et al.  Role of ABCC1 in export of sphingosine-1-phosphate from mast cells , 2006, Proceedings of the National Academy of Sciences.

[7]  J. Cyster,et al.  Finding a way out: lymphocyte egress from lymphoid organs , 2007, Nature Immunology.

[8]  M. Tani,et al.  Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes. , 2007, Biochemical and biophysical research communications.

[9]  R. Proia,et al.  S1P1 receptor directs the release of immature B cells from bone marrow into blood , 2010, The Journal of experimental medicine.

[10]  R. Proia,et al.  The alliance of sphingosine-1-phosphate and its receptors in immunity , 2008, Nature Reviews Immunology.

[11]  S. Milstien,et al.  Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics. , 2006, Cancer cell.

[12]  J. Harrow,et al.  A conditional knockout resource for the genome-wide study of mouse gene function , 2011, Nature.

[13]  Ying Xu,et al.  Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning , 2009, The Journal of experimental medicine.

[14]  Yannick Jacques,et al.  Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor , 2007, Nature Immunology.

[15]  Yiling Lu,et al.  Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. , 2006, Cancer cell.

[16]  R. Proia,et al.  The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. , 2007, Immunity.

[17]  H. Fyrst,et al.  An update on sphingosine-1-phosphate and other sphingolipid mediators. , 2010, Nature chemical biology.

[18]  O. Florey,et al.  Sphingosine 1-Phosphate Enhances Fcγ Receptor-Mediated Neutrophil Activation and Recruitment under Flow Conditions1 , 2009, The Journal of Immunology.

[19]  A. Melendez,et al.  A Critical Role for Sphingosine Kinase in Anaphylatoxin-Induced Neutropenia, Peritonitis, and Cytokine Production in Vivo 1 , 2005, The Journal of Immunology.

[20]  M. Zachariah,et al.  Follicular shuttling of marginal zone B cells facilitates antigen transport , 2008, Nature Immunology.

[21]  A. Yamaguchi,et al.  The Sphingolipid Transporter Spns2 Functions in Migration of Zebrafish Myocardial Precursors , 2009, Science.

[22]  J. Gamble,et al.  Human sphingosine kinase: purification, molecular cloning and characterization of the native and recombinant enzymes. , 2000, The Biochemical journal.

[23]  R. Proia,et al.  Expression of the Sphingosine 1-Phosphate Receptor, S1P1, on T-cells Controls Thymic Emigration* , 2004, Journal of Biological Chemistry.

[24]  V. Engelhard,et al.  Sphingosine Kinase 2 Is Required for Modulation of Lymphocyte Traffic by FTY720* , 2005, Journal of Biological Chemistry.

[25]  R. Gainetdinov,et al.  Plasma membrane monoamine transporters: structure, regulation and function , 2003, Nature Reviews Neuroscience.

[26]  H. Bonkovsky,et al.  Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate , 2008, Circulation research.

[27]  O. Volpert,et al.  Sphingosine 1‐phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  C. Feistritzer,et al.  Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. , 2005, Blood.

[29]  Ludwig Kappos,et al.  Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. , 2010, The New England journal of medicine.

[30]  T. Baumruker,et al.  The Balance between Sphingosine and Sphingosine-1-phosphate Is Decisive for Mast Cell Activation after Fc ⑀ Receptor I Triggering , 1999 .

[31]  Ying Xu,et al.  Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients , 2005, Science.

[32]  J. Kinet,et al.  Calcium mobilization via sphingosine kinase in signalling by the FcɛRI antigen receptor , 1996, Nature.

[33]  Cheng Luo,et al.  SPHINGOSINE-1-PHOSPHATE: A MISSING COFACTOR FOR THE E3 UBIQUITIN LIGASE TRAF2 , 2010, Nature.

[34]  M. Maceyka,et al.  Extracellular and intracellular actions of sphingosine-1-phosphate. , 2010, Advances in experimental medicine and biology.

[35]  H. Kiyono,et al.  Sphingosine 1-phosphate regulates peritoneal B-cell trafficking for subsequent intestinal IgA production. , 2007, Blood.

[36]  Masaru Ishii,et al.  The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. , 2012, The Journal of clinical investigation.

[37]  R. Proia,et al.  Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 , 2004, Nature.

[38]  J. Cyster,et al.  A Role for S1P and S1P1 in Immature-B Cell Egress from Mouse Bone Marrow , 2010, PloS one.

[39]  David K. Han,et al.  A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC). , 2007, Prostaglandins & other lipid mediators.

[40]  P. Gonzalez-Cabrera,et al.  Tipping the gatekeeper: S1P regulation of endothelial barrier function. , 2007, Trends in immunology.

[41]  Steven J Brown,et al.  Sphingosine 1-phosphate receptor signaling. , 2009, Annual review of biochemistry.

[42]  H. Rosen,et al.  Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists , 2002, Science.

[43]  J. P. Hobson,et al.  Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. , 2000, The Journal of clinical investigation.

[44]  S. Anderson,et al.  Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions , 2009, PloS one.

[45]  A. Bradley,et al.  A targeted X‐linked CMV‐Cre line , 2002, Genesis.

[46]  J. Chun,et al.  Dendritic cell PAR1–S1P3 signalling couples coagulation and inflammation , 2008, Nature.

[47]  S. Milstien,et al.  Molecular Cloning and Functional Characterization of a Novel Mammalian Sphingosine Kinase Type 2 Isoform* , 2000, The Journal of Biological Chemistry.

[48]  B. Kinzel,et al.  Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. , 2006, Blood.

[49]  Liang Zhi,et al.  Retracted: Sphingosine kinase 1 regulates pro‐inflammatory responses triggered by TNFα in primary human monocytes , 2006 .

[50]  Philippe Soriano,et al.  Widespread recombinase expression using FLPeR (Flipper) mice , 2000, Genesis.

[51]  R. Proia,et al.  Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism , 2006, The Journal of experimental medicine.

[52]  M. Gräler,et al.  Erythrocytes store and release sphingosine 1‐phosphate in blood , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  B. Kleuser,et al.  The role of sphingosine-1-phosphate receptor modulators in the prevention of transplant rejection and autoimmune diseases. , 2009, Current opinion in investigational drugs.

[54]  N. Gale,et al.  High Resolution Gene Expression Analysis in Mice Using Genetically Inserted Reporter Genes , 2006 .

[55]  S. Chae,et al.  Extracellular Export of Sphingosine Kinase-1 Enzyme , 2002, The Journal of Biological Chemistry.

[56]  A. Olivera Unraveling the complexities of sphingosine-1-phosphate function: the mast cell model. , 2008, Prostaglandins & other lipid mediators.

[57]  A. Yamaguchi,et al.  The Sphingosine 1-Phosphate Transporter, SPNS2, Functions as a Transporter of the Phosphorylated Form of the Immunomodulating Agent FTY720* , 2010, The Journal of Biological Chemistry.

[58]  J. Cyster,et al.  Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate , 2007, Science.

[59]  R. Proia,et al.  Mice Deficient in Sphingosine Kinase 1 Are Rendered Lymphopenic by FTY720* , 2004, Journal of Biological Chemistry.

[60]  Kosuke Yusa,et al.  The critical role of histone H2A-deubiquitinase Mysm1 in hematopoiesis and lymphocyte differentiation. , 2012, Blood.